Literature DB >> 7136517

Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria.

M L Bauman, T L Kemper.   

Abstract

The cerebra of three profoundly retarded adult males with untreated phenylketonuria (PKU) were systematically studied in terms of developmental morphology and histoanatomy against normal age-matched material, technically comparable in preparation. These studies were made possible by the availability of two extensive reference collections of normative neuroanatomic material, the Yakovlev and the Conel collections. The developmental parameters of myelination, width of the cortical plate, cell packing density, neuronal cell size, development of Nissl granulation, dendritic arborization and synaptic spine populations were studied. Our results indicate that there is a marked curtailment of histoanatomical maturation of the brain in PKU by all developmental parameters studied.

Entities:  

Mesh:

Year:  1982        PMID: 7136517     DOI: 10.1007/bf00692698

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  PHENYLKETONURIA PRESENTING AN INTERMITTENT PROGRESSIVE COURSE.

Authors:  M BECHAR; B BORNSTEIN; M ELIAN; U SANDBANK
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-04       Impact factor: 10.154

2.  Epinephrine metabolites and pigmentation in the central nervous system in a case of phenylpyruvic oligophrenia.

Authors:  J H FELLMAN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-02       Impact factor: 10.154

3.  Nucleolar and Nissl substance development in nerve cells.

Authors:  A LAVELLE
Journal:  J Comp Neurol       Date:  1956-04       Impact factor: 3.215

4.  Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system.

Authors:  G A JERVIS
Journal:  Proc Soc Exp Biol Med       Date:  1953-03

5.  Phenylacetate and brain dysfunction in experimental phenylketonuria: synaptic development.

Authors:  Y H Loo; T Fulton; K Miller; H M Wisniewski
Journal:  Life Sci       Date:  1980-10-06       Impact factor: 5.037

6.  Purkinje cell dendritic development in experimental phenylketonuria. A quantitative analysis.

Authors:  O Robain; G Y Wen; H M Wisniewski; J W Shek; Y H Loo
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 7.  Phenylketonuria: epitome of human biochemical genetics (first of two parts).

Authors:  C R Scriver; C L Clow
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

8.  Central nervous system lesions in disorders of amino-acid metabolism. A neuropathological study.

Authors:  J J Martin; W Schlote
Journal:  J Neurol Sci       Date:  1972       Impact factor: 3.181

9.  Myelin deficiency in experimental phenylketonuria: contribution of the aromatic acid metabolites of phenylalanine.

Authors:  Y H Loo; J Scotto; H M Wisniewski
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

10.  Choline acetyltransferase-containing neurons in rodent brain demonstrated by immunohistochemistry.

Authors:  H Kimura; P L McGeer; F Peng; E G McGeer
Journal:  Science       Date:  1980-05-30       Impact factor: 47.728

View more
  41 in total

1.  Platelet Na+, K+-ATPase activity as a possible peripheral marker for the neurotoxic effects of phenylalanine in phenylketonuria.

Authors:  M Bedin; C H Estrella; D V Duarte; D Ponzi; C S Dutra-Filho; A T Wyse; M Wajner; C M Wannmacher
Journal:  Metab Brain Dis       Date:  2000-06       Impact factor: 3.584

Review 2.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

3.  Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging.

Authors:  U Bick; G Fahrendorf; A C Ludolph; P Vassallo; J Weglage; K Ullrich
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

Review 4.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

5.  Effects of a co-treatment with pyruvate and creatine on dendritic spines in rat hippocampus and posterodorsal medial amygdala in a phenylketonuria animal model.

Authors:  Eleonora Araújo Dos Reis; Elenara Rieger; Sthefanie Souza de Souza; Alberto Antonio Rasia-Filho; Clóvis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2013-02-22       Impact factor: 3.584

Review 6.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

7.  Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.

Authors:  Carolina G Fernandes; Guilhian Leipnitz; Bianca Seminotti; Alexandre U Amaral; Angela Zanatta; Carmen R Vargas; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2009-09-23       Impact factor: 5.046

8.  Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study.

Authors:  A M Paans; J Pruim; G P Smit; G Visser; A T Willemsen; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia.

Authors:  N Kyprianou; E Murphy; P Lee; I Hargreaves
Journal:  J Inherit Metab Dis       Date:  2009-03-13       Impact factor: 4.982

Review 10.  The inherited leukodystrophies: a clinical overview.

Authors:  J Aicardi
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.